Incorporation of exon-4 of SAMHD1 has been linked to a higher prevalence of HBV- and HCV-related HCC, which leads to an abnormal SAMHD1 translation termination that weakens the anti-tumor activity of SAMHD1 [61,71]. This evidence concerns the gene SAMHD1 and neoplasm.